Odyssey Group International (Odyssey Group International) Debt-to-Equity : 0.17 (As of Jan. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Odyssey Group International Debt-to-Equity?

Odyssey Group International's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was $1.49 Mil. Odyssey Group International's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was $0.00 Mil. Odyssey Group International's Total Stockholders Equity for the quarter that ended in Jan. 2024 was $8.67 Mil. Odyssey Group International's debt to equity for the quarter that ended in Jan. 2024 was 0.17.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Odyssey Group International's Debt-to-Equity or its related term are showing as below:

ODYY' s Debt-to-Equity Range Over the Past 10 Years
Min: -1.32 Med: -0.4 Max: 0.17
Current: 0.17

During the past 9 years, the highest Debt-to-Equity Ratio of Odyssey Group International was 0.17. The lowest was -1.32. And the median was -0.40.

ODYY's Debt-to-Equity is ranked better than
55.57% of 709 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs ODYY: 0.17

Odyssey Group International Debt-to-Equity Historical Data

The historical data trend for Odyssey Group International's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Odyssey Group International Debt-to-Equity Chart

Odyssey Group International Annual Data

Trend

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Debt-to-Equity

Get a 7-Day Free Trial

-1.32

-0.40

-0.27

-0.33

-0.35

Odyssey Group International Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Debt-to-Equity	Get a 7-Day Free Trial															-0.34	-0.33	-0.35	-0.38	0.17

Competitive Comparison of Odyssey Group International's Debt-to-Equity

For the Medical Devices subindustry, Odyssey Group International's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Odyssey Group International's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Odyssey Group International's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Odyssey Group International's Debt-to-Equity falls into.

Odyssey Group International Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Odyssey Group International's Debt to Equity Ratio for the fiscal year that ended in Jul. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.145	+	0)	/	-6.156
	=	-0.35

Odyssey Group International's Debt to Equity Ratio for the quarter that ended in Jan. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.485	+	0)	/	8.67
	=	0.17

Odyssey Group International (OTCPK:ODYY) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Odyssey Group International Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Odyssey Group International's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Odyssey Group International (Odyssey Group International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Odyssey Group International Inc (OTCPK:ODYY) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

2300 West Sahara Avenue, Suite 800 - No. 4012, Las Vegas, NV, USA, 89102

Website

https://www.odysseyhealthinc.com

Odyssey Group International Inc is a company focused on developing life-saving medical products, Odyssey's goal is to create, acquire and accumulate distinct assets, intellectual property, and technologies that provide meaningful medical solutions. The Company is focused on building and acquiring assets in areas that have an identified technological advantage, provide superior clinical utility, and have a substantial market opportunity.

Executives

Erik C. Emerson	other: Chief Commercial Officer	2300 WEST SAHARA AVENUE, SUITE 800 - #4012, LAS VEGAS NV 89102
Gregory W Gironda	other: Chief Operating Officer	2300 WEST SAHARA AVENUE, SUITE 800 - #4012, LAS VEGAS NV 89102
Ricky Richardson	director	2372 MORSE AVE., IRVINE CA 92614
Christine Farrell	officer: Controller/Secretary	2372 MORSE AVE, IRVINE CA 92614
John P Gandolfo	director	62 TERRACE ROAD, WAYNE NJ 07470
Jerome H Casey	director	2372 MORSE AVE, IRVINE CA 92614
Jeffrey X Conroy	director	2372 MORSE AVE, IRVINE CA 92614
Vanlandingham Jacob Ph.d	director	2372 MORSE AVE, IRVINE CA 92614
J Michael Redmond	director, officer: President/CEO	10 CANTERBURY ROAD, WINDHAM NH 03087